EP1231900A1 - Zweischichttabletten zur applikation in der mundhöhle enthaltend nicotin - Google Patents

Zweischichttabletten zur applikation in der mundhöhle enthaltend nicotin

Info

Publication number
EP1231900A1
EP1231900A1 EP00979743A EP00979743A EP1231900A1 EP 1231900 A1 EP1231900 A1 EP 1231900A1 EP 00979743 A EP00979743 A EP 00979743A EP 00979743 A EP00979743 A EP 00979743A EP 1231900 A1 EP1231900 A1 EP 1231900A1
Authority
EP
European Patent Office
Prior art keywords
tablet
release
substance
tablet according
nicotine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00979743A
Other languages
English (en)
French (fr)
Inventor
Calum Park
Dale Munday
David Francis Bain
Omar Shakoor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robert Gordon University
Original Assignee
Robert Gordon University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9927525.7A external-priority patent/GB9927525D0/en
Priority claimed from GB0021645A external-priority patent/GB0021645D0/en
Application filed by Robert Gordon University filed Critical Robert Gordon University
Publication of EP1231900A1 publication Critical patent/EP1231900A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
EP00979743A 1999-11-23 2000-11-22 Zweischichttabletten zur applikation in der mundhöhle enthaltend nicotin Withdrawn EP1231900A1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9927525.7A GB9927525D0 (en) 1999-11-23 1999-11-23 Delivery of substances
GB9927525 1999-11-23
GB0021645A GB0021645D0 (en) 2000-09-04 2000-09-04 Delivery of substances
GB0021645 2000-09-04
PCT/GB2000/004428 WO2001037814A1 (en) 1999-11-23 2000-11-22 Bilayered buccal tablets comprising nicotine

Publications (1)

Publication Number Publication Date
EP1231900A1 true EP1231900A1 (de) 2002-08-21

Family

ID=26244959

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00979743A Withdrawn EP1231900A1 (de) 1999-11-23 2000-11-22 Zweischichttabletten zur applikation in der mundhöhle enthaltend nicotin

Country Status (3)

Country Link
EP (1) EP1231900A1 (de)
AU (1) AU1713501A (de)
WO (1) WO2001037814A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002085119A1 (en) * 2001-04-20 2002-10-31 Lavipharm Laboratories Inc. Intraoral delivery of nicotine for smoking cessation
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
WO2004056363A2 (en) 2002-12-20 2004-07-08 Niconovum Ab A physically and chemically stable nicotine-containing particulate material
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
JP4931596B2 (ja) 2003-11-07 2012-05-16 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
EP1937414A4 (de) * 2005-09-19 2013-01-02 Univ Witwatersrand Jhb Oromucosale arzneimittelverabreichungsform
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
EP1980245A1 (de) * 2007-04-11 2008-10-15 Cephalon France Gefriergetrocknete pharmazeutische Zweischicht-Zusammensetzungen sowie Methoden zur Herstellung und Verwendung derselben
AU2009303979A1 (en) * 2008-10-14 2010-04-22 Mcneil Ab Multi portion intra-oral dosage form and use thereof
EP2233134A1 (de) 2009-03-27 2010-09-29 McNeil AB Mehrteilige intraorale Darreichungsform mit organoleptischen Eigenschaften
US9017718B2 (en) * 2009-05-21 2015-04-28 Bionex Pharmaceuticals Llc Dual and single layer dosage forms
US20220347095A1 (en) * 2009-10-30 2022-11-03 Ix Biopharma Ltd Solid Dosage Form
TR201902233T4 (tr) * 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
FR2993778B1 (fr) * 2012-07-30 2016-06-17 Pf Medicament Pastilles a cinetiques multiples de liberation de principes actifs
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
WO2016145373A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
AU2018205529B2 (en) 2017-01-06 2023-08-10 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
KR101998288B1 (ko) * 2018-03-09 2019-07-09 (주)씨엘팜 무연 담배용 조성물 및 이를 포함하는 구강 용해 필름형 무연 담배
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
CN112444466B (zh) * 2019-09-05 2023-02-28 上海新型烟草制品研究院有限公司 一种用于评价口含烟烟碱体外吸收的方法
CN112220756B (zh) * 2020-10-16 2023-06-13 重庆市义力医药科技有限公司 一种尼古丁颗粒组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236713A (en) * 1987-10-21 1993-08-17 Teikoku Seiyaku Kabushiki Kaisha Preparation for intermittently releasing active agent applicable to oral cavity
DE69104045T2 (de) * 1990-07-23 1995-02-02 Alza Corp Oral anzuwendende osmotische vorrichtung zur abgabe von nicotin.
FR2718020B1 (fr) * 1994-04-01 1996-05-31 Biotec Centre Sa Composition galénique mucoadhésive hétérofonctionnelle.
DE19715594A1 (de) * 1997-04-15 1998-10-22 Bayer Ag Analgetika-Kombination
EP1107730B1 (de) * 1998-09-03 2008-03-12 Jsr Nti Llc Medikamentöse verabreichung von nikotin in form von kaugummi

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0137814A1 *

Also Published As

Publication number Publication date
AU1713501A (en) 2001-06-04
WO2001037814A9 (en) 2002-09-06
WO2001037814A1 (en) 2001-05-31

Similar Documents

Publication Publication Date Title
WO2001037814A1 (en) Bilayered buccal tablets comprising nicotine
US8501160B2 (en) Crush-resistant oxycodone tablets intended for preventing accidental misuse and unlawful diversion
Basak et al. Formulation and Release Behaviour of Sustained Release Ambroxol Hydrochloride HPMC Matrix Tablet.
JP4426286B2 (ja) ０次、０次−二相性、上昇型又は下降型薬物放出のための薬物送達システム
AU764346B2 (en) Pharmaceutical composition for the treatment of acute disorders
EP1731142A1 (de) System zur Freisetzung mit verzögertem Bursteffekt
US20030108602A1 (en) Tablets and methods for modified release of hydrophilic and other active agents
KR20080084858A (ko) 구강 경점막 전달을 위한 생접착성 약물 제형
JPH072649A (ja) 有効成分を徐放するための多層マトリックス系
EA011446B1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
JPS62267221A (ja) 新規薬物製剤
JPH0729924B2 (ja) プソイドエフエドリンおよびブロムフエニラミンの投与用製剤
JP2002275053A (ja) 医薬錠剤及びその製造のための方法
CA2500062A1 (en) Fast-release administration form with slightly soluble active ingredient
CN100589793C (zh) 一种在胃液中漂浮并多脉冲释放活性物质的药用片剂系统、该系统和该系统包封物的制备方法
AU2004258953B2 (en) Antibiotic product, use and formulation thereof
JPS587605B2 (ja) 徐放性製剤およびその製造法
AU2004258949B2 (en) Antibiotic product, use and formulation thereof
Budhrani et al. Mucoadhesive buccal drug delivery system: a review
EP2392318A1 (de) Pharmazeutische Zusammensetzung mit gesteuerter Freisetzung aus Losartan
JP3731612B2 (ja) 口腔粘膜貼付ブプレノルフィン製剤
AU2004270170B2 (en) Antibiotic product, use and formulation thereof
Dalvi et al. Novel approach and current application of bilayer tablet-A review
Kumar et al. Current Innovation in Layered Tablet Technology
Eraga et al. A Comparative Evaluation of Fast Dissolving Tablets of Acetaminophen Using Super-disintegrant Blends and Sublimation Method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020612

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20040210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040821